Questions: V(D)J Recombination and Antibody Diversity Generation

Question 1

Two B cells independently select the same V, D, and J gene segments for their heavy chain variable region. Their antibodies will therefore have identical antigen-binding sites.

• T. True
• F. False

Answer: False

Even with identical segment selection, junctional diversity ensures the two cells almost certainly have different sequences. TdT adds random non-templated N nucleotides at the V-D and D-J junctions, and asymmetric hairpin opening produces palindromic P nucleotides — both processes are stochastic and independent in each cell. The common misconception is that combinatorial diversity (segment choice) is the whole story; in reality, junctional diversity contributes as much or more to the final repertoire.

Question 2

Which enzyme is the primary source of junctional diversity during V(D)J recombination?

• A. RAG1/RAG2, which introduce DNA double-strand breaks at recombination signal sequences
• B. Terminal deoxynucleotidyl transferase (TdT), which adds random non-templated nucleotides at cut junctions
• C. DNA ligase IV, which seals the processed coding ends together
• D. Artemis nuclease, which opens the hairpin-sealed coding ends

Answer: (B)

TdT is the unique enzyme responsible for N-nucleotide addition — it adds random bases at the coding junctions without any template strand, introducing sequence variation that is completely unpredictable. RAG1/RAG2 initiate the cuts (they determine WHERE recombination happens, not the sequence variation at junctions), Artemis opens hairpins (generating P nucleotides, a lesser contributor), and ligase IV closes the ends. None of the others introduce the extensive random nucleotide variation that TdT does.

Question 3

V(D)J recombination achieves an antibody repertoire of over 10¹¹ sequences primarily because of the large number of V, D, and J gene segments available for combinatorial selection.

• T. True
• F. False

Answer: False

Combinatorial diversity alone — multiplying the number of V × D × J segment choices and heavy-light chain pairings — yields roughly 10⁶ possible antibodies. It is junctional diversity (random N and P nucleotide additions and deletions at each junction) that multiplies this by several orders of magnitude to reach 10¹¹. This is a critical distinction: segment selection provides the 'skeleton' of diversity, but the random junctional modifications are what make each B cell essentially unique even when the same segments are chosen.

Question 4

A researcher blocks TdT activity in developing B cells so that N nucleotides cannot be added during V(D)J recombination. Which outcome is most likely?

• A. B cell development stops completely because TdT is required for RAG-mediated DNA cleavage
• B. V(D)J recombination still occurs and antibody genes are assembled, but the resulting antibody repertoire is dramatically less diverse
• C. Antibody diversity is unaffected because combinatorial segment selection still generates sufficient variation
• D. Heavy chains cannot form at all, but light chains are unaffected since they only use V and J segments

Answer: (B)

TdT is not required for the recombination process itself — RAG1/RAG2 still cut at RSS sequences, and NHEJ machinery still ligates the ends. However, without N-nucleotide addition, the junctional region sequence is determined only by P nucleotides and any exonuclease nibbling, dramatically reducing junctional diversity. Option C is the target misconception: combinatorial diversity alone only reaches ~10⁶, far below the full repertoire. Option D is wrong because TdT acts at all junctions including heavy chain, but its absence doesn't prevent light chain rearrangement mechanistically.

Question 5

Why does V(D)J recombination use non-homologous end joining (NHEJ) rather than homologous recombination, and what consequence does this have for antibody diversity?

Model answer: NHEJ is used because the two coding ends being joined (e.g., a V segment end and a DJ junction) have no sequence homology — they are different gene segments, not copies of the same sequence. Homologous recombination requires a template with extensive sequence identity and would not create new sequences; it would restore the original sequence. NHEJ, by contrast, is an error-prone repair mechanism that processes the broken ends imprecisely: exonucleases may remove bases, and TdT adds random N nucleotides before ligation. This imprecision is the feature, not a bug — each ligation event produces a unique junction sequence, multiplying the antibody repertoire far beyond what segment selection alone could achieve.

The key insight is that NHEJ is 'chosen' precisely because it is imprecise — its lack of template-directed repair is what allows junctional diversity. The tradeoff is that roughly two-thirds of rearrangements produce frameshifts or stop codons, which is why B cells undergo allelic exclusion and attempt a second rearrangement if the first fails. The system accepts massive wastage in exchange for near-unlimited diversity.